An Interview Series with Members of the ASHP Expert Panel on Formulary Management: Part 3: Sabrina W. Cole, PharmD.
نویسنده
چکیده
This article presents the third in a series of three interviews that P&T conducted with several members of the American Society of Health-System Pharmacists (ASHP) Expert Panel on Formulary Management.In 2008, ASHP convened this panel of experts to develop revised guidelines for P&T committee and formulary management to replace the previous guidance issued in 1991.1 These revised guidelines include recommendations concerning the review and evaluation of drugs for formulary inclusion, pharmacoeconomic assessments, therapeutic interchange, medication-use evaluations (MUEs), management of drug shortages, and many other important topics.In this series, ASHP experts discuss P&T committee and formulary management guidelines in their respective institutions as well as other observations and insights. In Part 3, the author interviews Sabrina Cole, PharmD, Clinical Specialist, Drug Information, at the Grady Health System in Atlanta, Georgia.
منابع مشابه
An Interview Series with Members of the ASHP Expert Panel on Formulary Management: Part 1: Linda S. Tyler, PharmD.
Dr. Tyler: We feel that disclosure annually by individuals supports our process. We ask our P&T committee members to declare whether or not they have any conflicts of interest. The disclosures are shared with the committee but are also reviewed by a separate committee. Some members may have relationships with industry, such as serving on advisory boards, receiving research funding, or receiving...
متن کاملAn Interview Series with Members of the ASHP Expert Panel on Formulary Management: Part 2: J. Russell May, PharmD.
staff during their orientation in July. It is also available on our Web site. Monitoring adherence to these guidelines and other associated medical safety issues is an ongoing part of our antimicrobial stewardship program. Outcomes are reported back to the P&T committee for information and action. Examples of medication safety and therapeutic outcomes initiatives include venous thromboembolism ...
متن کاملASHP guidelines on the pharmacy and therapeutics committee and the formulary system.
Purpose These guidelines outline the recommended processes and techniques for formulary system management and describe the pharmacist's responsibilities and roles in managing the formulary system in partnership with other health care professionals. These guidelines also provide assistance to pharmacists in the organization and operation of the pharmacy and therapeutics (P&T) committee or equiva...
متن کاملTransparency in evidence evaluation and formulary decision-making: from conceptual development to real-world implementation.
OBJECTIVE Establishing a better understanding of the relationship between evidence evaluation and formulary decision-making has important implications for patients, payers, and providers. The goal of our study was to develop and test a structured approach to evidence evaluation to increase clarity, consistency, and transparency in formulary decision-making. STUDY DESIGN The study comprised th...
متن کاملClinical practice guidelines for the sustained use of sedatives and analgesics in the critically ill adult.
Judith Jacobi, PharmD, FCCM, BCPS; Gilles L. Fraser, PharmD, FCCM; Douglas B. Coursin, MD; Richard R. Riker, MD; Dorrie Fontaine, RN, DNSc, FAAN; Eric T. Wittbrodt, PharmD; Donald B. Chalfin, MD, MS, FCCM; Michael F. Masica, MD, MPH; H. Scott Bjerke, MD; William M. Coplin, MD; David W. Crippen, MD, FCCM; Barry D. Fuchs, MD; Ruth M. Kelleher, RN; Paul E. Marik, MDBCh, FCCM; Stanley A. Nasraway, ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- P & T : a peer-reviewed journal for formulary management
دوره 35 1 شماره
صفحات -
تاریخ انتشار 2010